Publications by authors named "Raymond W Fitzpatrick"

Claim this Profile
I
Investigation of the hospital pharmacy profession in Europe.
Darija Kuruc Poje, Raymond William Fitzpatrick, Claire Stevens, Carl Machin, Jonathan Underhill

Eur J Hosp Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database.
Stefanie Ho Yi Chan, Raymond W Fitzpatrick, Deborah Layton, Sherael Webley, Sam Salek

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis.
Stephen Robert Chapman, Mohammed Ibrahim Aladul, Raymond William Fitzpatrick

BMJ Open· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in UK healthcare professionals' knowledge, attitude and practice towards infliximab and insulin glargine biosimilars.
Mohammed I Aladul, Raymond W Fitzpatrick, Stephen R Chapman

Int J Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of new biosimilars in rheumatology and gastroenterology specialities on UK healthcare budgets: Results of a budget impact analysis.
Mohammed I Aladul, Raymond W Fitzpatrick, Stephen R Chapman

Res Social Adm Pharm· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of EAHP's 2018 Survey on Medicines Shortages.
Nenad Miljković, Nicholas Gibbons, Aida Batista, Raymond William Fitzpatrick, Jonathan Underhill

Eur J Hosp Pharm· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study.
Mohammed Ibrahim Aladul, Raymond William Fitzpatrick, Stephen Robert Chapman

BMJ Open· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK.
Mohammed I Aladul, Raymond W Fitzpatrick, Stephen R Chapman

BioDrugs· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey.
Mohammed I Aladul, Raymond W Fitzpatrick, Stephen R Chapman

BioDrugs· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has cost inhibited the uptake of more potent statins in England?
Stephen R Chapman, Raymond W Fitzpatrick, Mohammed I Aladul

Pharmacoepidemiol Drug Saf· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey.
Stephen R Chapman, Raymond W Fitzpatrick, Mohammed I Aladul

BMJ Open· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences.
Stephen R Chapman, Raymond W Fitzpatrick, Mohammed I Aladul

BMJ Open· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital pharmacy staffing levels in England: has anything changed in the last 5 years?
Raymond W Fitzpatrick, Susan Sanders

Eur J Hosp Pharm· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of NICE guidance on the prescribing of hormonal treatments of breast cancer in England.
Raymond W Fitzpatrick, Ronald G Pate

J Eval Clin Pract· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom.
Raymond W Fitzpatrick, Catherine M C Edwards

Pharm World Sci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis